MFSD2B activators are a category of chemical compounds that are known to modulate the function of the Major Facilitator Superfamily Domain containing 2B (MFSD2B) transporter. This specific transporter is part of a larger family of proteins that facilitate the movement of small molecules across cellular membranes. The MFSD2B activators typically exert their influence by engaging with the complex biochemical pathways of sphingolipid metabolism. Sphingolipids are a diverse group of compounds that play crucial roles in membrane structure and cell signaling. The activators work by increasing the availability of sphingolipid substrates that the MFSD2B transporter handles, thereby enhancing its activity. They may do this either by directly providing sphingolipid molecules or by modulating the levels of enzymes and intermediates in the sphingolipid metabolic pathway.
The mechanisms of action of MFSD2B activators are varied and can involve a number of biochemical interactions. Some of these compounds are analogs or precursors of sphingolipids themselves, integrating into and modifying the natural flow of the sphingolipid metabolic processes. For instance, molecules like sphingosine or ceramides can be metabolized into active sphingolipids that serve as substrates for the MFSD2B transporter. On the other hand, some activators may interact with enzymes that regulate the synthesis or degradation of sphingolipids, thereby adjusting the concentration of transporter substrates indirectly. This indirect modulation can result from either inhibition or enhancement of enzyme activity within the sphingolipid metabolic pathway. Additionally, some activators influence secondary messenger systems, such as cyclic AMP (cAMP), which can lead to a cascade of intracellular events affecting the metabolism of sphingolipids and, consequently, the activity of the MFSD2B transporter.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) is an endogenous ligand for sphingosine-1-phosphate receptors, which can enhance the activity of MFSD2 lysolipid transporter B by promoting sphingolipid signaling, a pathway where MFSD2B is inherently involved to regulate the cellular uptake of sphingolipids. | ||||||
L-α-Lysophosphatidylcholine (from egg yolk) | 9008-30-4 | sc-473611 sc-473611A sc-473611B sc-473611C | 25 mg 100 mg 500 mg 1 g | $87.00 $235.00 $607.00 $1102.00 | 1 | |
Lysophosphatidylcholine (LPC) can be integrated into sphingolipid metabolism, indirectly enhancing the activity of MFSD2 lysolipid transporter B by increasing the pool of substrates necessary for its transport function. | ||||||
Sphingomyelin | 85187-10-6 | sc-201381 sc-201381A | 100 mg 500 mg | $180.00 $560.00 | 3 | |
As a primary sphingolipid, sphingomyelin's breakdown products can enhance the activity of MFSD2 lysolipid transporter B by providing a steady supply of sphingolipids for transport, thus indirectly influencing the functional capacity of the transporter. | ||||||
Fingolimod | 162359-55-9 | sc-507334 | 10 mg | $160.00 | ||
Fingolimod is a sphingosine analog that indirectly enhances the functional activity of MFSD2 lysolipid transporter B by modulating sphingosine-1-phosphate levels, thus influencing sphingolipid-dependent signaling pathways. | ||||||
Phytosphingosine | 554-62-1 | sc-201385 sc-201385A | 5 mg 25 mg | $102.00 $427.00 | 4 | |
Phytosphingosine is a sphingolipid that can enhance the activity of MFSD2 lysolipid transporter B by increasing the sphingolipid substrate levels in the cellular environment, thus indirectly facilitating the transporter's functional capacity. | ||||||
Sphingosylphosphorylcholine, D-erythro | 1670-26-4 | sc-201384 | 10 mg | $408.00 | 1 | |
Sphingosylphosphorylcholine influences sphingolipid-mediated signaling and can enhance the activity of MFSD2 lysolipid transporter B by modulating the levels of sphingolipid molecules available for transport. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
Cyclic AMP (cAMP) can indirectly enhance the activity of MFSD2 lysolipid transporter B by activating protein kinase A (PKA), which influences various cellular processes including those that could lead to the increased availability of sphingolipid substrates for MFSD2B. | ||||||